Improved product rebranding, introduction of new product packing across a wide spectrum and increased market penetration helped boost GlaxoSmithKline consumer Nigeria Plc’s (GLAXOSMI) 2013FY results.
The pharmaceutical company, a unit of UK’s biggest drug makers for the year ended 31 December 2
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
